|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 49.2 USD | +0.13% |
|
+1.92% | -4.14% |
| 11:29am | Novartis Nominates Former Bristol Myers Squibb CEO as New Chair | MT |
| 11:12am | Novartis Lifts 2024 Guidance as First-quarter Earnings Grow on Strong Blockbuster Drug Demand | MT |
Bristol-Myers Squibb Company revised earnings guidance for the year 2022. Total Net Sales expects same as previous of approx. $47.0 billion or low single-digit increase.
Diluted EPS now expects $2.92-$3.22 compared to previous guidance of $3.37-$3.67.
| 1st Jan change | Capi. | |
|---|---|---|
| -4.14% | 99.59B | |
| +27.50% | 659B | |
| +27.68% | 557B | |
| -4.11% | 359B | |
| +16.45% | 322B | |
| +9.72% | 297B | |
| +6.30% | 215B | |
| +4.80% | 210B | |
| -6.05% | 200B | |
| -8.75% | 149B |
BRISTOL-MYERS SQUIBB COMPANY 
